Uluslar Arası Yayınlar
-
21 October 2020117
Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages
Coskun U, Sancak B, Sen I, Bukan N, Tufan MA, Gülbahar O, Sozen S. Serum P-selectin, soluble vascular cell adhesion molecule-I…
Read More » -
21 October 2020136
Digital ischemic changes after gemcitabine therapy in a patient with metastatic non-small-cell lung cancer.
Yildiz R, Coskun U, Kaya AO, Ozturk B, Yaman E. Digital ischemic changes after gemcitabine therapy in a patient with metastatic…
Read More » -
21 October 2020144
F-18 FDG uptake due to acinetobacter infection causing misinterpretation of treatment response in a lymphoma patient.
Yildiz R, Coskun U, Kapucu O, Kaya AO, Akdemir UO, Benekli M, Buyukberber S. F-18 FDG uptake due to acinetobacter…
Read More » -
21 October 2020153
Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?
Coskun U, Yamac D, Gulbahar O, Sancak B, Karaman N, Ozkan S. Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are…
Read More » -
21 October 2020164
Solitary iris metastasis from breast cancer with dramatic course: case report.
Ozturk B, Buyukberber S, Coskun U, Yaman E, Yildiz R, Kaya AO, Oner Y, Benekli M. Solitary iris metastasis from breast…
Read More » -
21 October 2020141
Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer.
Acar A, Onan A, Coskun U, Uner A, Bagriacik U, Atalay F, Unsal DK, Guner H. Clinical significance of serum…
Read More » -
21 October 2020148
The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinoma.
Ozturk B, Buyukberber S, Akmansu M, Coskun U, Yamac D, Uner A, Yaman E, Yildiz R, Kaya AO, Bora H, Unsal…
Read More » -
21 October 2020124
Serum and Ascitic Fluid Superoxide Dismutase and Malondialdehyde Levels in Patients with Cirrhosis. Biomark Insights.
Ozenirler S, Sancak B, Coskun U. Serum and Ascitic Fluid Superoxide Dismutase and Malondialdehyde Levels in Patients with Cirrhosis. Biomark Insights. 2008…
Read More » -
21 October 2020164
Synchronize primary breast osteosarcoma and contralateral benign cystosarcoma phylloides: radiologic and pathologic imaging.
Uner A, Ozturk B, Benekli M, Coskun U, Kocak S, Kaya AO, Unsal D, Erekul S, Yaman E, Yildiz R, Buyukberber…
Read More » -
21 October 2020143
Reply to the article “oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases” by J.-J. Body et al.
Yaman E, Benekli M, Coskun U, Ozturk B, Kaya AO, Yildiz R, Buyukberber S. Reply to the article “oral ibandronate…
Read More »
